Minke; Jules Maarten
Patent Applications and Registrations
Patent applications and USPTO patent grants for Minke; Jules Maarten.The latest application filed is for "canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof".
Company Profile
1.21.25
- Minke; Jules Maarten - Nice FR
- Minke; Jules Maarten - Corbas FR
Patent Activity
| Patent | Date |
|---|---|
| Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof Grant 10,537,632 - David , et al. Ja | 2020-01-21 |
| Hendra virus recombinant compositions and uses thereof Grant 10,350,287 - Audonnet , et al. July 16, 2 | 2019-07-16 |
| Canine Parvovirus (CPV) Virus-like Particle (VLP) Vaccines and uses thereof App 20190000965 - David; Frederic ; et al. | 2019-01-03 |
| Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof Grant 10,080,798 - David , et al. September 25, 2 | 2018-09-25 |
| Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom Grant 10,006,050 - Mebatsion , et al. June 26, 2 | 2018-06-26 |
| Recombinant Poxviral Vectors Expressing both Rabies and OX40 Proteins, and Vaccines Made Therefrom App 20170137843 - Mebatsion; Teshome ; et al. | 2017-05-18 |
| Hendra Virus Recombinant Compositions And Uses Thereof App 20170087242 - Audonnet; Jean-Christophe ; et al. | 2017-03-30 |
| Canine Parvovirus (CPV) Virus-like Particle (VLP) Vaccines and uses thereof App 20170087244 - David; Frederic ; et al. | 2017-03-30 |
| Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom Grant 9,567,606 - Mebatsion , et al. February 14, 2 | 2017-02-14 |
| Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof Grant 9,556,419 - Minke January 31, 2 | 2017-01-31 |
| Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof Grant 9,555,101 - Audonnet , et al. January 31, 2 | 2017-01-31 |
| Recombinant Equine Herpesvirus-1 Vaccine Containing Mutated Glycoprotein C And Uses Thereof App 20150190502 - Audonnet; Jean Christophe ; et al. | 2015-07-09 |
| Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof Grant 8,916,371 - Audonnet , et al. December 23, 2 | 2014-12-23 |
| Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof App 20140314807 - Minke; Jules Maarten | 2014-10-23 |
| Vaccine Against African Horse Sickness Virus App 20140120133 - Minke; Jules Maarten ; et al. | 2014-05-01 |
| Recombinant Equine Herpesvirus-1 Vaccine Containing Mutated Glycoprotein C And Uses Thereof App 20130251747 - Audonnet; Jean Christophe ; et al. | 2013-09-26 |
| Recombinant vaccine against West Nile Virus Grant 8,535,682 - Loosmore , et al. September 17, 2 | 2013-09-17 |
| Recombinant Poxviral Vectors Expressing both Rabies and OX40 Proteins, and Vaccines Made Therefrom App 20130209511 - Mebatsion; Teshome ; et al. | 2013-08-15 |
| Hendra Virus Recombinant Compositions And Uses Thereof App 20120301479 - AUDONNET; Jean-Christophe ; et al. | 2012-11-29 |
| Vaccine Against African Horse Sickness Virus App 20120114691 - Minke; Jules Maarten ; et al. | 2012-05-10 |
| Vaccine against african horse sickness virus Grant 8,168,200 - Minke , et al. May 1, 2 | 2012-05-01 |
| Vaccines against vesicular stomatitis Grant 8,008,268 - Yao , et al. August 30, 2 | 2011-08-30 |
| Recombinant Vaccine Against West Nile Virus App 20100221282 - LOOSMORE; SHEENA MAY ; et al. | 2010-09-02 |
| Recombinant vaccine against West Nile Virus Grant 7,740,863 - Loosmore , et al. June 22, 2 | 2010-06-22 |
| Vaccine Against African Horse Sickness Virus App 20100119546 - Minke; Jules Maarten ; et al. | 2010-05-13 |
| Live recombined vaccines injected with adjuvant Grant 7,507,416 - Audonnet , et al. March 24, 2 | 2009-03-24 |
| Vaccine against streptococci Grant 7,455,844 - Minke , et al. November 25, 2 | 2008-11-25 |
| Canine Influenza Vaccines App 20080241184 - Minke; Jules Maarten ; et al. | 2008-10-02 |
| Canine influenza vaccines Grant 7,425,336 - Minke , et al. September 16, 2 | 2008-09-16 |
| Canine influenza vaccines Grant 7,384,642 - Minke , et al. June 10, 2 | 2008-06-10 |
| Vaccines against vesicular stomatitis App 20080124357 - Yao; Jiansheng ; et al. | 2008-05-29 |
| Vaccine Against Streptococci App 20070243195 - Minke; Jules Maarten ; et al. | 2007-10-18 |
| Canine influenza vaccines App 20070048819 - Minke; Jules Maarten ; et al. | 2007-03-01 |
| Canine influenza vaccines App 20070048821 - Minke; Jules Maarten ; et al. | 2007-03-01 |
| Adjuvant-containing vaccines Grant 7,163,926 - Audonnet , et al. January 16, 2 | 2007-01-16 |
| Live recombined vaccines injected with adjuvant App 20060057163 - Audonnet; Jean-Christophe Francis ; et al. | 2006-03-16 |
| Recombinant vaccine against West Nile Virus App 20050255127 - Loosmore, Sheena May ; et al. | 2005-11-17 |
| Recombinant vaccine against West Nile Virus App 20050031641 - Loosmore, Sheena May ; et al. | 2005-02-10 |
| Live recombined vaccines injected with adjuvant Grant 6,713,068 - Audonnet , et al. March 30, 2 | 2004-03-30 |
| Recombinant vaccine against West Nile Virus App 20040037848 - Audonnet, Jean-Christophe Francis ; et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 